Logo
x

Search

Subscribe Now

Eton

Insights+: The US FDA New Drug Approvals in November 2021

Insights+: The US FDA New Drug Approvals in November 2021

  • December 16, 2021
Eton and Azurity’s Eprontia (topiramate) Receives the US FDA’s Approval for the Treatment of Seizures and Migraines

Eton and Azurity’s Eprontia (topiramate) Receives the US FDA’s Approval for the Treatment of Seizures and Migraines

  • November 8, 2021
Insights+: The US FDA New Drug Approvals in June 2021

Insights+: The US FDA New Drug Approvals in June 2021

  • July 15, 2021
Disease of the Month: Cerebral Palsy

    Disease of the Month: Cerebral Palsy

    • October 18, 2022
    Insights+: The US FDA New Drug Approvals in November 2021

      Insights+: The US FDA New Drug Approvals in November 2021

      • December 16, 2021
      Eton and Azurity’s Eprontia (topiramate) Receives the US FDA’s Approval for the Treatment of Seizures and Migraines

        Eton and Azurity’s Eprontia (topiramate) Receives the US FDA’s Approval for the Treatment of Seizures and Migraines

        • November 8, 2021
        BioMarin Reports FDA

          BioMarin Reports FDA's Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU

          • September 6, 2021
          Insights+: The US FDA New Drug Approvals in June 2021

            Insights+: The US FDA New Drug Approvals in June 2021

            • July 15, 2021
            United Therapeutics Reports the First Patient Enrollment in P-III TETON Study of Tyvaso for Idiopathic Pulmonary Fibrosis

              United Therapeutics Reports the First Patient Enrollment in P-III TETON Study of Tyvaso for Idiopathic Pulmonary Fibrosis

              • June 4, 2021
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.